UCI plans to ban corticosteroids under same rules as tramadol
President David Lappartient says the substance will be forbidden on health grounds


The UCI has unveiled plans to ban powerful corticosteroids because of concerns over rider safety.
Corticosteroids are an anti-inflammatory medicine prescribed for a range of health conditions, including asthma and injury to joints, muscles and tendons.
Some versions, like nasal sprays or injections to joints are allowed in competition, but others like intravenous injections and pills are banned in races and require a therapeutic use exemption (TUE).
The World Anti-Doping Agency (WADA) says that glucocorticoids, a class of corticosteroids, “seem to be performance enhancing.”
>>> Video shows moment man left in critical condition after being kicked off bike by cyclist
But the international governing body is now looking to ban the substance on the grounds of rider safety, not performance enhancement, Reuters reports. (opens in new tab)
UCI president David Lappartient told the news organisation: “We named a group of experts to show it is dangerous for your health.
“We are hopeful to be ready to ban it for the beginning the 2020. The idea is to not have corticosteroids in our sport in 2020.”
Lappartient said he intends to ban corticosteroids in the same way as tramadol, the opiate painkiller prohibited by the UCI since the start of March.
Tramadol, which is frequently used by riders according to WADA, was banned by the UCI despite not being on the banned list of the international anti-doping authority.
>>> Jess Varnish appeals against British Cycling and UK Sport tribunal decision
WADA says it is not convinced tramadol has performance-enhancing benefit, but that it could be banned in the coming years.
Corticosteroids hit the headlines in 2016 when a group of Russian hackers leaked athletes’ therapeutic use exemptions.
The leak revealed Sir Bradley Wiggins had permission to inject triamcinolone, a corticosteroid, prior to the 2011 and 2012 editions of the Tour, and the 2013 Giro d’Italia – his season’s goals for those years.
Wiggins was granted the TUEs to treat a pollen allergy, but a report by the Digital, Culture, Media and Sport Committee (DCMS) found that Team Sky “crossed and ethical line” in giving Wiggins the substance.
David Millar, a retired pro who confessed to doping before becoming a campaigner against performance enhancing drugs, said triamcinolone had a major impact on his performance on the bike.
Thank you for reading 5 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1
Alex Ballinger is editor of BikeBiz magazine, the leading publication for the UK cycle industry, and is the former digital news editor for CyclingWeekly.com. After gaining experience in local newsrooms, national newspapers and in digital journalism, Alex found his calling in cycling, first as a reporter, then as news editor responsible for Cycling Weekly's online news output, and now as the editor of BikeBiz. Since pro cycling first captured his heart during the 2010 Tour de France (specifically the Contador-Schleck battle) Alex covered three Tours de France, multiple editions of the Tour of Britain, and the World Championships, while both writing and video presenting for Cycling Weekly. He also specialises in fitness writing, often throwing himself into the deep end to help readers improve their own power numbers. Away from the desk, Alex can be found racing time trials, riding BMX and mountain bikes, or exploring off-road on his gravel bike. He’s also an avid gamer, and can usually be found buried in an eclectic selection of books.
-
-
David Millar: Why Mark Cavendish deserves to be at the Tour de France
Cav has bridged generations in a way no one else could, he shows what's possible
By David Millar • Published
-
Young and talented: Meet the seven Americans racing Le Tour
Young and talented: Meet the seven American bike racers ringing Le Tour de France in 2022.
By Marshall Opel • Published
-
UCI tightens rules for transgender cyclists: Two year wait before competition allowed
Changes following Emily Bridges's move to compete will come into effect on 1 July 2022
By Tom Thewlis • Published
-
UCI president David Lappartient defends promotion and relegation system: 'It certainly has its advantages for the competition'
The top-18 teams of the UCI's rankings based on results over the past three seasons will be awarded a three-year WorldTour licence
By Ryan Dabbs • Published
-
TV drone has short-lived debut in live broadcast after UCI intervenes to ban them mid-race
The drone didn't even have enough time to run out of charge before it was yanked out of the sky by cycling's governing body
By Jonny Long • Published
-
Female pros want a separate Under 23s World Championships, not a race within a race, The Cyclists' Alliance says
Limited support for UCI plan to introduce an U23 jersey, awarded from the elite road race
By Tim Bonville-Ginn • Published
-
UCI joins calls for governments to invest in cycling to battle carbon emissions
Cycling's governing body joined the ECF and others to write to governments attending COP26 in Glasgow
By Tim Bonville-Ginn • Published
-
UCI reveals final overall rankings for the 2021 season
No surprises in who has come out on top in both the men's and women's tables
By Tim Bonville-Ginn • Published
-
UCI partners with FIFA and other organisations to evacuate 165 Afghan refugees
The operation was helped by owner of Israel Start-Up Nation, Sylvan Adams
By Tim Bonville-Ginn • Published
-
UCI announces gravel World Championships, new cyclocross format and 'the development of snow bike'
Gravel cycling has gained huge popularity in the last few years with the UCI hoping to harness that for new races
By Tim Bonville-Ginn • Published